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Abstract: 
The prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) of small            
molecules from their molecular structure is a central problem in medicinal chemistry with great              
practical importance in drug discovery. Creating predictive models conventionally requires          
substantial trial-and-error for the selection of molecular representations, machine learning (ML)           
algorithms, and hyperparameter tuning. A generally applicable method that performs well on all             
datasets without tuning would be of great value but is currently lacking. Here, we describe               
Pareto-Optimal Embedded Modeling (POEM), a similarity-based method for predicting         
molecular properties. POEM is a non-parametric, supervised ML algorithm developed to           
generate reliable predictive models without need for optimization. POEM’s predictive strength is            
obtained by combining multiple different representations of molecular structures in a           
context-specific manner, while maintaining low dimensionality. We benchmark POEM relative to           
industry-standard ML algorithms and published results across 17 classifications tasks. POEM           
performs well in all cases and reduces the risk of overfitting. 
 
  
Introduction: 
Chemical activity predictions continue to present a longstanding challenge with practical            
importance during pharmaceutical research and development. In particular, predictive tasks that           
associate chemical structures to their activity are known as Quantitative Structure Activity            
Relationships (QSARs) (​1​). In modern drug design programs, QSARs are used for modeling             
specific target biological activities or broader pharmacokinetic behaviours, including the          
absorption, distribution, metabolism, excretion, and toxicity of drug candidate molecules,          
collectively referred to as ​ADMET ​(​2​–​4​). All machine learning (ML) approaches to predict             
chemical activity have three fundamental requirements: [1] a ​library of diverse reference            
molecules with a known property to predict (labeled examples), [2] a form of molecular              
representation and [3] a discriminative supervised learning algorithm. In practical drug discovery            
applications, multiple algorithms and molecular representations are explored and optimized on a            
trial-and-error basis (​5​), since their performance varies considerably from predictive task to            
predictive task. This process generates final models which can vary considerably, even between             
extremely similar predictive tasks, in a manner that is seemingly arbitrary and often difficult to               
interpret.  
 
Molecular representations are a key component for predictive modeling of chemical activity.             
Different representations can be more or less relevant to different predictive tasks, not unlike the               
context-dependent use of different molecular representations in a laboratory. For example,           
acetylsalicylic acid can be described by several different common names: IUPAC name,            
chemical formula (C​9​H​8​O​4​), a simplified molecular-input line-entry system (SMILES) string (eg.           
“O=C(C)Oc1ccccc1C(=O)O”) (​6​, ​7​), or a drawing of a 2-D structure (eg. as in Figure 1). Each of                 
these representations is valid, but describe acetylsalicylic acid with differing levels of information             
content. For example, Acetozone has the same chemical formula as acetylsalicylic acid, but not              
the same 2-D structure; this is consistent with the observation that the chemical formula is a                
higher entropy description of a molecule than a drawing of its 2-D structure. For most ML                
applications, the molecular representation is defined in a way that is much simpler for a               
computer to extract useful information from, such as a binary or numeric vector (eg. Figure 1E).  
 
Physicochemical molecular descriptors are one conceptually simple way to create such a             
vector: by measuring a series of known properties (eg. mass, number of heteroatoms, charge,              
etc.) (​8​). While physicochemical descriptors have favorable interpretability, these overly          
simplistic representations of a molecule can lead to poor predictive power or a host of other                
problems associated with incorrect descriptor selections (​9​). Thus, an approach relying on            
physicochemical molecular descriptors may be robust for a single predictive task, but often will              
not be generalizable.  
 
Alternatively, molecules may be converted into a vector format in a process called molecular               
fingerprinting (​10​). Unlike physicochemical molecule descriptors, fingerprints do not need to           
have any human-obvious relationship to the properties of the molecule; they are generated by              
following strict algorithmic rules that associate individual positions in the vector to the             
presence/absence of specific substructures and substructure relationships. A primary         
advantage gained by using fingerprints, as opposed to purely physicochemical molecular           
descriptors, is that they are usually much more generalizable; a fingerprint of a molecule will               
often be useful to some degree across many different problems. Unfortunately, this generality             
comes with a lack of specificity, and risks training a model on syntactic features of the                
representation (“noise”) rather than true details of the structure (​11​).  
 
Most fingerprinting methods do lose information upon encoding, resulting in vectors that             
tentatively represent several different molecules (​12​, ​13​). Typically, the loss of information is             
coupled to specific advantages such as improved speed, lower memory usage, algorithmic            
advantages, or increased density of useful information. For instance, Daylight fingerprints can            
exist as long, variable length fingerprints, or they can be ‘folded’ into a fixed-length              
representation, gaining speed and memory efficiency at the cost of reversibility (​10​). In addition              
to losing information, compressed (folded) fingerprints are prone to introducing algorithmic           
noise, leading to potential false equivalencies. While reversibility may be desirable in some             
applications, its is not always necessary.  
 
The relationship between molecular features and chemical activity is established during the             
training stages of supervised learning algorithms. Chemical activities are predicted using           
industry-standard ML approaches for supervised learning, such support vector machines          
(SVMs), random forest modeling, ridge classification and neural networks. Typically, each           
algorithm has its own specific set of ​hyperparameters that influence the performance of the              
trained models. The problem of knowing which hyperparameters to use is itself an interesting              
and non-trivial topic of research (​14​). In practice, the optimal combination of hyperparameter             
values also varies across tasks and must be calibrated through a trial-and-error based             
optimization process. This high computational cost of retraining models can be a deterrent for              
incorporating new training data at a later stage, although this drawback is partially mitigated in               
some neural network based approaches through recent advances in transfer learning (​15​, ​16​).             
When a supervised learning algorithm successfully establishes relationships between molecular          
features and chemical activities, the resulting model can be used to predict the chemical activity               
of new, previously unseen molecules.  
 
Model interpretability is another important factor in the selection of supervised learning             
algorithms. Some algorithms, for example decision trees, provide human interpretable          
justifications for the associations between molecular features and chemical activities. For other            
algorithms, such as neural networks, the reasons for any given prediction can often be              
extremely hard to determine. In practice, the “black box” nature of these models can inhibit trust                
and possibly reduce the real-world utility of the model. Understanding this rationale can lead to               
new strategies for reducing bias, overfitting, and possibly even improve theory (​17​). Ideally,             
each prediction generated by the model has a clear rationale behind it, which can be               
understood by the researcher using the model. 
 
Unfortunately, the combination of variable context-dependent molecular representations,         
choice of supervised learning algorithms and hyperparameterization is typically inconsistent          
between predictive tasks. Any specific combination of these three factors optimized for a             
specific chemical activity model will not be applicable to predicting other activities. In practice,              
prediction of seemingly related chemical properties may end up requiring models with different             
molecular features, algorithms, and/or parameters following substantial development effort by          
expert chemoinformaticians.  
 
One approach to addressing inconsistency in the choice of molecular fingerprints and             
tentatively boosting performance is to use multiple fingerprints simultaneously as features. It is             
clear that distinct molecular representations possess varying amounts of useful information           
relating to specific problems (​i.e. each molecular representation discards information, but not            
every method discards ​the same information). So, two fingerprints of the same molecule             
produced by two different low-information fingerprint methods will share some redundant           
information about the structure, and contain some unique information. By combining molecular            
representations, a greater amount of “true” information can be captured from the complete             
structure of the molecule. A naive way to combine molecular representations is to append the               
vectors generated by each fingerprint directly onto each other, to create a new, longer              
fingerprint, of multiple types. This approach has at least two major disadvantages: [1] for some               
supervised learning algorithms, the computational costs may become prohibitive when          
concatenating multiple fingerprints, due to increased length of the vector; and [2], the             
concatenation approach is prone to the creatively named “curse of dimensionality” (​18​–​20​). This             
phenomenon occurs when the ratio of training data to features is low, and overfitting becomes               
not just possible, but likely. Other methods approach this issue by using voting schemes to try to                 
weigh consensus between models built using different fingerprints (​21​), or by nesting the             
selection of a fingerprint with hyperparameter selection to empirically determine the most            
effective fingerprint (​22​). 
 
In this report, we describe Pareto-Optimal Embedded Modelling (POEM), a novel supervised             
learning method that reliably creates accurate models for predicting drug activity based on             
multiple representations of molecular structure. POEM evades the ​curse of dimensionality by            
using pareto multi-front optimization (​23​, ​24​) to massively shrink the number of dimensions that              
define molecular similarity, in a context-dependent manner. A Pareto optimization algorithm is a             
powerful general approach for identifying optimal solutions in cases where there are more than              
one metric to optimize, that may not always be in agreement with each other. It has found broad                  
applications including protein structure minimization (​25​, ​26​) and lead optimization in drug            
design (​27​). Effectively, the context-dependent dimensionality reduction introduced by POEM          
enables the use of multiple fingerprints to describe every molecule in the reference molecule              
library, without introducing a risk of overfitting. The specific use of a pareto-based approach to               
defining similarity ensures that all comparisons remain ‘like-to-like’ and avoids the need for             
heuristic transformations and weighting schemas. POEM also has a number of additional            
functional advantages: the rationale for predictions are each interpretable, the algorithm has no             
hyperparameters, and models can be easily updated with new labeled reference molecules.            
This approach was designed for the rapid generation of multiple predictive models, without the              
need for expert intervention. We demonstrate the generalizability and consistency of POEM            
across a broad range of predictive tasks by modeling 17 ADMET properties of interest to               
pharmaceutical drug development.  
  
 
Materials and Methods: 
 
Strategy 
POEM uses a Pareto dominance definition to combine multiple definitions of molecular             
similarity, into a robust metric suitable for supervised learning tasks. The POEM method has              
four major steps: [1] fingerprinting, [2] embedding the known molecules into a limited context              
based on similarity, [3] calculating Pareto dominance relationships for the known molecules, and             
[4] converting these dominance relationships into similarity scores and predictions. A high-level            
flowchart describing this process and the outputs at each step is provided in Figure S1.  
 
Step 1: Fingerprinting 
​N molecular fingerprints techniques are applied to the target molecule and the reference              
library of ​M labeled compounds. Step 1 results in a matrix of ​M​x​N fingerprints for reference                
library and a vector of ​N fingerprints for the reference molecule. For this study, ten diverse and                 
widely-used fingerprints were chosen. Detailed parameters and references for these ten           
fingerprints are provided in TABLE S1.  
 
Step 2: Embedding Known Molecules 
The fingerprint representations of the target molecule are embedded onto the chemical             
landscape of the reference library via a non-reversible transformation. For each fingerprint,            
Tanimoto distances (28) (Figure 1E) are calculated between the target molecule and all             
reference molecules in the library. Step 2 results in a matrix of ​M​x​N distance values, centered                
on the target molecule. 
 
Step 3: Calculating Dominance Relationships 
Although each molecule in the reference library is represented by a set of ​N distances, the                 
specific values of the distances are not directly comparable. A distance of 0.4 may represent a                
significant match for one fingerprint, but random noise for another. To resolve this issue, Pareto               
dominance relationships are used to establish an overall distance. Here, the target molecule is              
selected as the ​ideal objective for multi-front optimization and the set of fingerprints represents              
N​-dimensional space (27, 29). Dominance relationships between molecules from the reference           
library defined on the basis of which molecule is ​closer to the target. One reference library                
molecule may be closer than another to the target for all ​N distances, or a subset of the ​N                   
dimensions. When evaluating the dominance of one reference library molecule (​A​) to another             
labeled molecule (​B​) across all 10 distances, closer distances are assigned a value of 1, ties                
are assigned a value of 0.5, and further distances are assigned a value of 0. A comparison                 
vector ​AB = [1, 0, 1, 0.5, 0, 0.5, 0.5, 1, 1, 1] would indicate that molecule A is more similar to the                       
target molecule in five fingerprint representations, tied in three representations, and more            
dissimilar using two fingerprint representations. Step 3 results in an ​M​x​M symmetric matrix of              
dominance relationships.  
 
In a naive Pareto scheme, a molecule would ​dominate another molecule all its distances               
were as close or closer to the target molecule, and at least one distance was closer (​26​). POEM                  
relaxes the naive definition of dominance, allowing a molecule to claim dominance over another,              
even if <=10% of its distance comparisons remain further from the target. In practice, this               
relaxation yields more dominance relationships overall when a larger number of fingerprints is             
used. The added dominance relationships reduce the likelihood of ties, which helps establish a              
complete ranking of all molecules in the labeled library relative to the target. Sample code for                
evaluating these relationships is provided in Supplemental Pseudocode 1. 
  
Step 4: Calculating Fitness Scores and Final Prediction 
  
Labeled reference molecules are ranked by their similarity to the target molecule by converting              
dominance relationships to a single-value ​fitness score​. For a given molecule, its fitness is              
defined as:  
 
Fitness_{i} = MeanDominance_{i} \cdot \frac{(NumDominating_{i} + 0.05)}{(NumSubmitting_{i} +        
0.05)} 
 
This schema favors labeled reference molecules which compare favorably “on average” for all              
fingerprints (​MeanDominance​), which dominate many other molecules (​NumDominating​), and         
which are not being dominated by others (​NumSubmitting​). This approach favors labeled            
molecules that are “best-of-class” across all metrics of similarity to the target molecule. Sample              
code for ranking molecules is provided in Supplemental Pseudocode 2.  
 
Labeled reference molecules are ranked according to their fitness scores and summed to              
provide a “total fitness” value. In practice, fitness values vary by orders of magnitude between               
the most similar and dissimilar molecules. In some cases, the top few molecules could              
contribute the vast majority of the weight towards the summed fitness value. Alternatively,             
contribution towards the total fitness value may be more broadly distributed across the             
reference molecule library. The relative contribution of each labeled reference molecule to the             
total fitness score is then used as a weight towards each observed class label. Weighted               
averages are treated as probabilities of the target having any given label. Sample code              
evaluating probabilities is provided in Supplemental Pseudocode 3. Step 4 results in a Length ​M               
fitness vector of similar molecules, which is used to assign probabilities to each label class.  
 
Benchmarking POEM to Standard Approaches with 17 ADMET property predictions 
POEM was benchmarked relative to five standard supervised learning algorithms, across 17             
predictive tasks related to drug ADMET properties. All 17 ADMET datasets were taken from              
public sources and range between 522 and 6505 labeled reference molecules. Each molecule             
was represented by a SMILES string. RDKit release 2018.09.1 was used to parse, canonicalize,              
and featurize small molecules. Molecules that could not be automatically processed by RDKit             
and molecules that have both positive and negative data labels were excluded from each              
dataset. Redundant data points representing experimental replicates were also removed. The           
Supplementary Text contains references and descriptions for each dataset used in this study,             
including the total number of training examples for each label after dataset cleaning. Python’s              
scikit-learn package v0.19.1 (​30​) was used to build models for each of the five standard               
supervised learning algorithms: Gradient Boosting Classifier, Random Forest, Ridge Classifier,          
Stochastic Gradient Descent Classifier, and Support Vector Machine, representing a range of            
industry-standard supervised classifier types, which are suitable for the dataset sizes in this             
benchmark study. Each of the five standard supervised learning algorithms was trained using a              
grid search strategy for hyperparameter optimization, with an added nested layer evaluating            
performance separately for each of the fingerprints listed in Table S1. In contrast, POEM has no                
hyperparameters and considers all fingerprints simultaneously. In addition, a Molecule Graph           
Convolution (31, 32) model was trained using the GraphConv model in the DeepChem python              
package (33), on all 17 datasets, to provide a comparison to state-of-the-art deep neural              
network methods. Results are reported both from a naive model with default parameters (2              
convolution layers of size 64, one dense layer of 128, 75 features per atom, 10 training epochs),                 
and a hyperparameter optimized model (parameters selected after 20 rounds of 5-fold            
cross-validated Bayesian optimization, for reference see Table S4). Finally, we also evaluated            
POEM models that were limited to using only individual fingerprints, to provide an added              
comparison to a non-consensus, similarity-based classifier approach.  
 
Cross validation of predictive models  
For each of the five standard supervised learning approaches, models were trained and              
evaluated with a five-fold cross-validation strategy, using 80% of the dataset for training and              
hyperparameter optimization and withholding 20% for blind performance evaluation. The same           
80% / 20% split was used to create a ​POEM test set​, which provides a direct comparison to the                   
five standard algorithms. POEM is also amenable to full ‘leave-one-out’ cross validation due to              
the lack of a computationally-expensive training process. This corresponding ​POEM Full Set            
evaluation provides an indication of predictive robustness with respect to dataset size.            
Additionally, nested cluster validation was performed as in Mayr ​et al. ​(34), with the added               
restriction that the test set must contain at least one example of each class.  
 
Results: 
 
POEM outperforms five standard supervised learning methods for predicting 17 ADMET           
properties 
 
Table 1 provides a comparison between POEM performance relative to the top performing              
fingerprint/algorithm combinations generated from standard supervised learning approaches,        
across 17 different ADMET tasks. Across all tasks, the ​POEM Test Set outperforms the              
standard supervised learning algorithms, as determined by ROC area under the curve (AUC)             
score, in some cases by more than 10% (Figure 2). Additionally POEM performs approximately              
as well, or better, than the GraphConv neural network (Figure 2). Validation scores associated              
with standard classifiers are consistently better than test scores (Figure 3), indicating some             
degree of overfitting. In contrast, the ​POEM Full Set scores are sometimes higher and              
sometimes lower than the ​POEM Test Set scores. Generally, similarity between these scores is              
an indication of predictive robustness and resistance to overfitting. A notable exception in both              
cases is the AR dataset, which shows the largest score disparity between the POEM Full Set​,                
POEM Test Set. This disparity and relatively low predictive performance may indicate an             
insufficient representation of chemical space in the underlying dataset. 
 
To assess predictive robustness with regards to the random test set selection, 100 different               
80% / 20% testing splits were performed on the Blood Brain Barrier (BBB) and the Caco-2                
Permeability (Caco2) datasets (Figure S2). ROC AUC was computed for all 100 using both              
POEM and the previously determined best model and hyperparameters for each approach (as             
reported in Table S2). Compared to the standard classifiers, the POEM performance is higher              
for each test set, and overall shows less variability. 
 
To assess POEM’s ability to generalize, a nested cluster validation approach was used. This               
approach provides insight into how well POEM can make predictions for molecules highly             
dissimilar to any known reference molecules. We see that POEM does generalize well,             
especially for certain datasets (eg. BBB in Figure S3), though in some other cases performance               
is poor on dissimilar molecules (eg. AR in Figure S3). This approach was also applied to the                 
GraphConv neural network, with comparably good results (Figure S4). 
 
We also compared POEM performance with literature-reported results for models trained on             
the same datasets. Kansen et al. report expert-optimized models for the Ames Mutagenicity             
dataset built using molecular descriptors and seven binary classification tools (​35​). The top             
performing model in that study was a support vector machine (SVM) with ROC AUC of 0.86,                
whereas the non-parametric POEM automatically generated comparable models with 0.87 AUC.           
This study shares three common datasets with AdmetSAR, a predictive tool that uses             
substructure-based descriptors and support vector machines (​36​). AdmetSAR reports five-fold          
cross-validation ROC AUC values for: Blood Brain Barrier (0.9517), Human Intestinal Absorption            
(0.9458), Caco-2 Permeability (0.8216). These models were generated using different          
combinations of three fingerprints and three binary classification algorithms (​36​). The Androgen            
Receptor (AR) activity dataset was taken from the Tox21 Challenge, a federal collaboration             
involving NIH, EPA and the FDA aimed to develop better toxicity assessment methods. For this               
sub-challenge, 31 teams contributed different predictive models, with the leading ROC AUC at             
0.828 (​37​). Consistently, POEM matched or outperformed expert-developed models reported in           
the literature. 
 
We also compared the standard POEM approach to a modified variation that uses individual               
fingerprints rather than a consensus of ten, reporting all ​leave-one-out cross validation results             
for each dataset in Table S3. As expected, the standard consensus approach performs reliably              
well, appearing among the top models for each task and clearly outperforming any individual              
single-fingerprint across all tasks. The use of multiple fingerprints consensus also helps            
establish meaningful confidence scores associated with the predictive tasks. Figure 4 presents            
the distribution of POEM-predicted probability for the ‘correct’ label for the Caco-2 permeability             
dataset, across the consensus 10FP POEM, and each of the ten single-fingerprint models. In              
this figure, data points that lie below 0.5 represent an incorrect prediction and points closer to                
100% and 0% represent higher confidence predictions. The Caco-2 dataset was chosen as an              
example dataset to demonstrate this principle, since the consensus approach ranked lower than             
three other single-fingerprint models. Performance varied across all fingerprinting methods, and           
was of approximately average predictive power overall. This figure demonstrates that the            
consensus model is better able to capture the confidence of a given prediction, as most of the                 
observed incorrect predictions were made with lower confidence than for the single-fingerprint            
models. The single-fingerprint models almost exclusively produce highly confident correct          
predictions, or highly confident incorrect predictions. 
  
Discussion: 
 
At its core, POEM is a method based on measuring similarity, conceptually similar to a                
K-nearest neighbor approach (​20​). The predictive power of the method is based on the              
assumption that molecules with similar structures have similar properties. This approach has an             
established tradition (​38​), and is not in itself novel. POEM differs from these other approaches               
by intentionally restricting comparisons to relative similarity (through the embedding stage).           
Information is lost during the transformation of quantitative distances to relative similarity, such             
that similarity relationships evaluated are only meaningful in the context of the specific target              
molecule and predictive task. Specifically, the magnitude of any given distance has variable             
significance across fingerprints and predictive tasks. By ignoring the quantitative distribution of            
Tanimoto distances and operating only on less/greater comparisons between like fingerprints,           
POEM’s treatment of reference molecule data is statistically ​non-parametric​. The transformation           
to a ‘distribution-free’ representation of distances sidesteps the need for fingerprint-related           
transformation functions, weights or voting schemas. In turn, the entire landscape of labeled             
reference molecules can be used in making each prediction in a consistent and systematic              
manner, without the need to introduce fingerprint-related hyper-parameters to optimize from           
task-to-task. This approach leads to fast and objective model building, two major functional             
advantages of the algorithm. 
 
While POEM’s treatment of input data is statistically non-parametric, modification to the             
algorithm itself may impact performance. For example, adding new fingerprints may further            
improve performance. Future studies on larger datasets may identify new such modifications            
that produce significantly different optimal configurations from task-to-task, leading to optional           
hyper-parameters and a potential for optimization. Nonetheless, the results in this study            
demonstrate consistent performance using a static algorithm configuration and fingerprint          
selection. In this context, POEM is a powerful general purpose supervised machine learning             
approach that does not require hyperparameter optimization. POEM was designed to reduce            
the need for highly-tuned models, crafted by ML experts. Conceptually, the POEM algorithm is              
also applicable to problems outside of chemistry, as long as the object of the prediction has                
multiple representations which have metrics to define similarity. 
 
 
 
 
We have shown that the increased performance and consistency of POEM is attributed to the                
use of multiple fingerprints simultaneously, as previously observed in other similarity           
approaches such as the ​Similarity Ensemble Approach ​(​38​). POEM models created using 10             
fingerprints outperform those created by individual fingerprints with few exceptions, which may            
be attributed to random variation. This is further supported by the observation that the optimal               
fingerprint differs on a task-by-task basis when evaluating the standard supervised learning            
methods (Table 1) or single fingerprint POEM models (Table S3). Even seemingly related tasks,              
such as Cytochrome P450 activity predictions, are best addressed with different fingerprints for             
different isoforms. If algorithmic noise is responsible for variation between models generated            
using different fingerprints or hyperparameters, then model performance may be compromised           
in subsequent real world applications. The use of multiple fingerprints simultaneously in POEM             
side-steps this issue, providing reliable performance across a range of predictive tasks. Efforts             
were initially made to also build predictive models for benchmarking using concatenated            
fingerprints, but computational runtime was deemed cost-prohibitive, demonstrating instead a          
distinct speed advantage to the POEM strategy for combining representations.  
 
POEM is also seen to generalize well, in terms of the ability to make predictions for molecules                  
unlike any known reference molecules (Figure S3). More specifically, we observe that it             
performs as well or better than the GraphConv neural network (Figure S4). This network in               
particular was chosen because it is known to be highly performative (31), and was also not too                 
cost-prohibitive (though we were forced to limit the amount of nested cluster validation to two               
properties due to compute cost concerns).  
 
While this study limits the scope of POEM to classification problems, the fundamental              
relationship between molecular similarity and activity established by POEM may provide a            
suitable framework for developing regression models. Preliminary findings applying POEM to           
four standard benchmark datasets presented in Supplemental Figure 5 demonstrate favorable           
performance over leading deep learning frameworks to develop regression models for chemical            
activity. Future studies using a broader range of datasets would provide a broader             
understanding on POEM’s utility towards regression problems. 
  
We have identified a number of functional advantages to POEM, including model building              
speed, reliability, predictive power, objectivity, ease of use, and model interpretability. POEM is             
particularly well suited to applications requiring automation due to its objective nature and             
reduced risk of overfitting. Highly automated applications may include: models built upon            
large-scale data mining expeditions, datasets with frequent updates, or model building by            
subject-area field experts without first-hand experience developing ML models. The          
similarity-based nature of this algorithm helps provide model interpretability, as each prediction            
is coupled with the list of reference molecules, their relative similarity, and their labels. 
 
The above notwithstanding, there are important trade-offs associated with the POEM            
approach. Mainly, POEM has high algorithmic complexity associated with the generation of an             
M​x​M dominance matrix. Due to POEM’s instance-based learning nature, predicting each           
unlabeled molecule scales proportionally with the square of the number of molecules in the              
reference molecule library. Algorithmically, this prediction stage is significantly slower when           
compared to other standard supervised learning methods. In practice however, POEM can            
handle datasets up to 100,000 training examples on modern personal computers (4 Core CPU,              
16Gb RAM, Ubuntu 18.04). Applying POEM to ligand-based virtual screening using libraries            
with millions of molecules may also impose a technical challenge, requiring distributed            
computing solutions. Future heuristic approximations may improve POEM dataset scalability,          
including batching the dominance calculations (which would move POEM to O(nlogn) time            
rather than O(n^2), at the cost of completely sorting all reference molecules). As it stands, we                
have not made these changes at present, as datasets of fewer than 10,000 reference molecules               
are still capable of performing predictions in the range of milliseconds to seconds. In our               
experience, these timescales are suitable for most practical applications in drug discovery.            
Nonetheless, even with regard to larger datasets, the lack of dedicated ‘training’ and             
‘optimization’ stages make up for limitations in speed in applications where fewer predictions             
need to be made. For instance, POEM models can be easily improved over time, without added                
computational cost, simply by adding new data into the set of labeled reference molecules.              
Additionally, we have observed that highly unbalanced datasets can behave poorly when using             
POEM to make predictions, and additional dataset balancing might be desirable for producing             
highly performant models.  
 
As is always the case with machine learning approaches, the main determinant for predictive               
performance is the nature and quality of the data used for training. This is observed here in the                  
contrast between good models (BBB, ERa and HIA) and bad models (Carcin, CYP), especially              
when looking at generalizability (Figure S2). Unfortunately, in the world of drug-property            
prediction, many of the best datasets are privately held, despite exciting but limited recent              
efforts to make some data available to researchers and the public (​39​).  
 
In spite of the above limitations, we consider POEM to be a valuable addition to the roster of                   
methods for supervised learning ​available today, especially given its lack of hyperparameters,            
high generalizability, and low cost. 
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Figures: 
 
Figure 1. Multiple representations of acetylsalicylic acid with varying levels of 
information. (A)​ a 2D representation that explicitly shows all atoms and bonds within ASA, ​(B) 
a 2D line-diagram of ASA with details removed but isomorphic to the previous diagram, ​(C)​ a 3D 
depiction of ASA which highlights the geometry between each atom, and ​(D)​ a 3D space-filled 
depiction of ASA, which gives a sense of relative atom sizes. ​(E)​ Simplified depiction of a 
hypothetical molecular fingerprint showing two molecules converted into unique bits that can be 
directly compared (e.g. bits are used to calculate Tanimoto similarity(​28​) or distance (1 - 
Tanimoto similarity)) 
 
Figure 2. Comparison of POEM performance versus industry-standard classifiers and 
literature reported values. ​ROC area under the curve (AUC) scores for​ ​POEM and 
industry-standard ML methods tasked with predicting 17 ADMET properties are compared. 
Shown are the ROC AUC scores for full leave-one-out prediction with POEM (POEM full set, 
black circles), a 20% test set with POEM (POEM test set, black triangles), and the same 20% 
test set for best performing fingerprint and hyperparameters for each industry-standard ML 
method (colored straight lines). In addition, reported scores from AdmetSAR (​36​) (gray 
squares), an ADMET prediction tool, other Literature Values (​31​, ​33​) (grey ovals), and a naive 
(gray diamonds) and hyperparameter optimized (gray rhomboids) GraphConv (31) neural 
network are also shown when applicable. 
 
Figure 3. Comparison of ROC AUC scores on test data versus leave-one-out cross 
validation scores (for POEM) or pre-validation scores (for industry-standard classifiers). 
(A)​ ROC AUC scores are shown (y-axis) for each best performing classifier, hyperparameter, 
and fingerprint combination, for each of the 17 properties, for the same 20% test set as used in 
the POEM comparisons, and the mean of the 5-fold cross-validation score (Pre-Validation ROC 
AUC, x-axis), as assessed during model training. A dotted line is shown as a reference along 
the diagonal. ​(B)​ Shown are the POEM ROC AUC scores for each of the 17 properties being 
predicted, for a 20% test set (y-axis), and for leave-one-out cross validation on the remaining 
80% set (the same set as in ​A​) (x-axis). A dotted line is shown as a reference along the 
diagonal.  
 
Figure 4. Comparison of individual leave-one-out POEM predictions of Caco-2 
permeability using 10-fingerprint consensus and 10 single fingerprints individually. ​Each 
point represents the POEM prediction probability of the correct label for a reference labelled 
molecule withdrawn from the training data for a leave-one-out complete cross-validation. A 
probability of 1.0 represents 100% certainty of the correct prediction, and 0.0 represents 100% 
certainty of the incorrect prediction. 
  
 
 
 
 
 
 
 
 
 
 
Tables: 
Table 1.​ A summary of the performance (ROC AUC score) of 17 ADMET properties of POEM 
and best-performing, standard classifier-fingerprint combination. POEM Test: 80%/20% testing 
split for a direct comparison to traditional approaches, POEM Full: ‘leave-one-out’ full 
cross-validation. 
 
Property 
POEM Full 
(ROC AUC) 
POEM Test 
(ROC AUC) 
Best 
Traditional 
(ROC AUC) Best Classifier 
Best 
Fingerprint 
AMES Toxicity 0.872 0.869 0.802 
Gradient 
Boosting Pattern 
Androgen 
Receptor 0.864 0.744 0.687 
Gradient 
Boosting Layered 
Blood Brain 
Barrier 0.979 0.981 0.916 
Stochastic 
Gradient 
Descent Pattern 
Caco-2 
permeability 0.828 0.822 0.726 
Gradient 
Boosting Pharm Gobbi 
Carcinogenic 0.726 0.659 0.678 
Gradient 
Boosting Layered 
CYP450 2C9 
Inhibitor 0.801 0.840 0.594 
Stochastic 
Gradient 
Descent Pharm Base 
CYP450 2C9 
Substrate 0.690 0.612 0.507 
Stochastic 
Gradient 
Descent Morgan Rad:4 
CYP450 2D6 
Inhibitor 0.750 0.718 0.566 
Stochastic 
Gradient 
Descent Pharm Base 
CYP450 2D6 
Substrate 0.778 0.688 0.594 Ridge Morgan Rad:2 
CYP450 3A4 
Inhibitor 0.700 0.677 0.613 
Gradient 
Boosting Pattern 
CYP450 3A4 
Substrate 0.676 0.586 0.532 
Gradient 
Boosting Morgan Rad:4 
Estrogen 
Receptor alpha 0.963 0.961 0.855 
Gradient 
Boosting Pharm Base 
Human 
Intestinal 
Absorption 0.949 0.954 0.883 
Stochastic 
Gradient 
Descent Layered 
Human Oral 
Bioavailability 0.770 0.763 0.676 
Gradient 
Boosting Pharm Base 
Human 
Pregnane X 
Receptor 0.895 0.876 0.646 Ridge Layered 
P-glycoprotein 
Inhibitor 0.945 0.954 0.885 
Gradient 
Boosting Pattern 
P-glycoprotein 
Recognition 0.955 0.943 0.855 Ridge Morgan Rad:2 
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Supplemental Methods 
Supplemental Pseudocode 1: Evaluating the dominance relationships 
""" 
calculate the dominance relationships between all the children in the set 
this refers to how much "closer" a child is to the template molecules, according to what numbers of methods 
:param vecs: The distances of one molecule from all training cases 
:param weights: array of weights for each fingerprint from 0.0-1.0 of how good the fp is 
:return: dominance matrix, dominant count, subordinate count. 
""" 
  
M : Number of molecules in training set 
N: Number of fingerprint types 
  
dom_matrix[i,j] : an MxM matrix that will contain the dominance scores. 
dom[i] : a vector of length M, listing the number of molecules dominated by each molecule i 
sub[i] : a vector of length M, listing the number of molecules that dominate each molecule i 
dist[k, i] : an MxN matrix of Tanimoto distances between the test molecule and molecule i, using fingerprint k 
  
# precompute scores 
score = [0.5 for k in 0 .. N] 
  
for i in 0 .. M: 
s = [0, 0, ..., 0] x M 
num_better = [0, 0, ...., 0] x M 
num_worse  = [0, 0, ...., 0] x M 
for k in 0 .. N: 
 v = dist[k,i] 
 c = 0.5 + sign(dist[k] - v) * score[k] 
 s = s + c 
 num_better = num_better + (1 where c > 0.75, 0 otherwise) 
 num_worse  = num_worse + (1 where c < 0.25, 0 otherwise) 
num_tied = N - (num_better + num_worse) 
dom_check = ((num_better + num_tied) / N) > 0.9 
sub_check = ((num_worse  + num_tied) / N) > 0.9 
  
dom_matrix[i] = s / N 
dom[i] += count(dom_check and not sub_check) 
sub[i] += count(sub_check and not dom_check) 
 
return dom_matrix, dom, sub 
 
Supplemental Pseudocode 2: Evaluating absolute distance rankings to target molecule 
""" 
calculate the final rankings, based on the dominance matrix/information 
""" 
fitness[i] : M dimensional vector that will contain the fitness values 
  
for i in 0 .. M: 
# the fitness is the sum of the dominance scores for each child 
s = sum(dom_matrix[i]) 
# then, weight the score by the number of children dominating it 
# this favors non-dominated children 
fitness[i] = (float(s)) * (dom[i] + 0.05)) / (sub[i] + 0.05) 
return fitness 
  
 ​Supplemental Pseudocode 3.  Evaluating the probability of each class label 
""" 
Compute the prediction probabilities 
"" 
  
Np : Number of property values (usually 2) 
  
fitness[k,i] : fitness vector for each property value k, as above. 
  
hit = [0, ..., 0] x Np  # compute all property values at once 
for i in 0 .. N: 
j = poem.molProp[i] # Value of property for molecule i 
hit[j] += fitness[j][i] 
probs = hit / sum(hit)  # Normalize probability 
  
# Predicted value is that with maximum probability in 'probs' 
 
 
Figure S1. Flowchart Outlining the POEM Algorithm 
 
 
Table S1. List of 10 fingerprints used by POEM, using the RDKit implementation 
Fingerprint Parameters 
AtomPair N/A 
RDKit Default (Daylight) N/A 
Layered N/A 
Morgan (Radius=2) Radius=2, useChirality=True, 
useFeatures=False 
Morgan (Radius=2) with Features Radius=2, useChirality=True, 
useFeatures=True 
Morgan (Radius=4) Radius=4, useChirality=True, 
useFeatures=False 
Morgan (Radius=4) with Features Radius=4, useChirality=True, 
useFeatures=True 
Pattern N/A 
PharmBase sigFactory:  
feat_defs = 
os.path.join(RDConfig.RDDataDir, 
'BaseFeatures.fdef') 
feat_factory = 
ChemicalFeatures.BuildFeatureFactory(feat_
defs) 
sig_factory = SigFactory(feat_factory, 
minPointCount=2, maxPointCount=3, 
trianglePruneBins=False) 
sig_factory.SetBins([(0, 2), (2, 5), (5, 8)]) 
sig_factory.Init() 
PharmGobbi sigFactory: 
rdkit.Chem.Pharm2D.Gobbi_Pharm2D.factor
y 
 
  
Supplemental Results 
Table S2. List of best-performing classifier, hyperparameter, and fingerprint for each of 
17 ADMET properties identified by grid search.  
Property Classifier Hyperparameters Fingerprint 
AMES Toxicity Gradient Boosting 
{'learning_rate': 
0.08, 'loss': 
'exponential', 
'max_depth': 7} Pattern 
Androgen Receptor Gradient Boosting 
{'learning_rate': 0.1, 
'loss': 'deviance', 
'max_depth': 5} Layered 
Blood Brain Barrier 
Stochastic Gradient 
Descent {'penalty': 'l1'} Pattern 
Caco-2 permeability Gradient Boosting 
{'learning_rate': 0.1, 
'loss': 'exponential', 
'max_depth': 5} Pharm Gobbi 
Carcinogenic Gradient Boosting 
{'learning_rate': 
0.08, 'loss': 
'exponential', 
'max_depth': 7} Layered 
CYP450 2C9 
Inhibitor 
Stochastic Gradient 
Descent 
{'penalty': 
'elasticnet'} Pharm Base 
CYP450 2C9 
Substrate 
Stochastic Gradient 
Descent {'penalty': 'l1'} Morgan Rad:4 
CYP450 2D6 
Inhibitor 
Stochastic Gradient 
Descent {'penalty': 'l1'} Pharm Base 
CYP450 2D6 
Substrate Ridge {'alpha': 5} Morgan Rad:2 
CYP450 3A4 
Inhibitor Gradient Boosting 
{'learning_rate': 
0.08, 'loss': 
'deviance', 
'max_depth': 7} Pattern 
CYP450 3A4 
Substrate Gradient Boosting 
{'learning_rate': 0.1, 
'loss': 'exponential', 
'max_depth': 7} Morgan Rad:4 
Estrogen Receptor 
alpha Gradient Boosting 
{'learning_rate': 0.1, 
'loss': 'exponential', 
'max_depth': 5} Pharm Base 
Human Intestinal 
Absorption 
Stochastic Gradient 
Descent 
{'penalty': 
'elasticnet'} Layered 
Human Oral 
Bioavailability Gradient Boosting 
{'learning_rate': 
0.08, 'loss': 
'exponential', 
'max_depth': 5} Pharm Base 
Human Pregnane X 
Receptor Ridge {'alpha': 1} Layered 
P-glycoprotein 
Inhibitor Gradient Boosting 
{'learning_rate': 0.1, 
'loss': 'exponential', 
'max_depth': 5} Pattern 
P-glycoprotein 
Recognition Ridge {'alpha': 5} Morgan Rad:2 
 
Table S3: Non-consensus POEM evaluated on each fingerprint and task ​separately. 
Performance is provided as the full leave-one-out cross validation ROC AUC score in each 
case. 
 
Dataset 10FP 
Atom 
Pair RDKit 
Layere
d 
Morga
n R2 
Morga
n R4 
Morga
n R2F 
Morga
n R4F 
Patter
n 
Pharm 
Base 
Pharm 
Gobbi 
AMES Toxicity 0.8718 0.8593 0.8565 0.8575 0.8605 0.8561 0.8701 0.8651 0.8445 0.7953 0.8097 
Androgen 
Receptor 0.8637 0.8652 0.8391 0.8519 0.8602 0.8605 0.8522 0.8567 0.8672 0.8382 0.8684 
Blood Brain 
Barrier 0.9789 0.9658 0.9553 0.9658 0.9694 0.9691 0.9662 0.9662 0.9630 0.9679 0.9728 
Caco-2 
permeability 0.8280 0.8286 0.7591 0.7891 0.8157 0.8170 0.8266 0.8300 0.7820 0.8049 0.8282 
Carcinogenic 0.7265 0.7049 0.7180 0.7322 0.7272 0.7149 0.7229 0.7141 0.7253 0.6395 0.7027 
CYP450 2C9 
Inhibitor 0.8015 0.7543 0.7410 0.7733 0.7613 0.7680 0.7842 0.7859 0.7826 0.7819 0.7602 
CYP450 2C9 
Substrate 0.6902 0.6843 0.6454 0.6787 0.6965 0.6935 0.6665 0.6696 0.6823 0.6776 0.6328 
CYP450 2D6 
Inhibitor 0.7504 0.7393 0.6825 0.6974 0.7433 0.7373 0.7153 0.7137 0.7237 0.7126 0.7283 
CYP450 2D6 
Substrate 0.7780 0.7858 0.7342 0.7665 0.7860 0.7844 0.7679 0.7675 0.7502 0.7804 0.7838 
CYP450 3A4 
Inhibitor 0.6997 0.6897 0.6720 0.6500 0.6936 0.6968 0.7001 0.7008 0.7075 0.6676 0.6623 
CYP450 3A4 
Substrate 0.6759 0.6873 0.6437 0.6391 0.6776 0.6694 0.6768 0.6716 0.6548 0.6360 0.6512 
Estrogen 
Receptor alpha 0.9630 0.9532 0.9437 0.9429 0.9579 0.9578 0.9619 0.9627 0.9422 0.9501 0.9501 
Human 
Intestinal 
Absorption 0.9488 0.9557 0.8777 0.9011 0.9560 0.9493 0.9532 0.9503 0.8807 0.8961 0.8904 
Human Oral 
Bioavailability 0.7704 0.7627 0.7293 0.7191 0.7533 0.7490 0.7606 0.7637 0.7088 0.7353 0.7498 
Human 
Pregnane X 
Receptor 0.8950 0.8996 0.7644 0.8637 0.8743 0.8781 0.9038 0.9013 0.8787 0.8475 0.8298 
P-glycoprotein 
Inhibitor 0.9447 0.9348 0.9111 0.9094 0.9380 0.9371 0.9411 0.9424 0.9320 0.9310 0.9300 
P-glycoprotein 
Recognition 0.9553 0.9349 0.8219 0.8929 0.9410 0.9395 0.9374 0.9373 0.9052 0.8896 0.9247 
 
Table S4: ROC AUC scores and optimized GraphConv hyper-parameters for each 
property prediction task. 
 
Property Naive 
AUC 
Optimized 
AUC 
Learning 
rate 
Batch 
size 
Gc 
Layer 
1 
Gc 
Layer 
2 
Dense 
layer 
Number 
Atom 
features 
AMES 0.875 0.876 0.000183 70 220 120 300 75 
AR 0.767 0.736 0.000103 70 70  310 70 
BBB 0.979 0.981 0.000184 10 500 230 350 75 
Caco2 0.798 0.810 0.003091 30 110 160 70 70 
Carcin 0.692 0.688 0.044583 90 70  430 70 
CYP2C9I 0.695 0.685 0.010737 80 260  170 75 
CYP2C9S 0.564 0.607 0.006779 80 240  150 75 
CYP2D6I 0.743 0.741 0.000134 30 110  180 80 
CYP2D6S 0.744 0.700 0.000337 80 80 90 120 75 
CYP3A4I 0.643 0.628 0.016852 30 360 90 100 75 
CYP3A4S 0.609 0.622 0.022635 80 460  440 80 
ERa 0.957 0.958 0.000146 50 250 140 300 80 
HIA 0.899 0.968 0.001435 10 110  150 85 
HOB 0.718 0.720 0.000103 70 180 410 60 75 
hPXR 0.868 0.872 0.003037 20 260  110 75 
PgpI 0.939 0.933 0.072239 40 100  140 75 
PgpR 0.937 0.951 0.000151 10 130  100 75 
 
 
 
 
Figure S2. Comparison of Blood Brain Barrier (BBB) and Caco-2 Permeability (Caco2) 
ROC AUC score distributions. ​Shown are standard box plots of the distribution of ROC AUC 
scores from either a withheld 20% test-set (red) or an 80% ‘training’ set (blue) that represents 
the pre-validation scores for the industry-standard methods, or the leave-one-out 
cross-validation scores on the same reference molecule library when used by POEM. Model 
performance was calculated from 100 random splits, each split being used to generate both a 
POEM model, and an industry-standard model, for BBB and Caco2 (using their respective best 
method, fingerprint, and parameters, as listed in Table S2). 
 
 
Figure S3. Nested cluster validation of POEM models for 17 ADMET properties. ​Shown are 
standard box plots of the distribution of ROC AUC scores from ten repeats of a nested cluster 
validation (34). Points are overlaid, and show the ROC AUC scores directly, colored to indicate 
the ratio of molecules in the test set relative to the ‘training’ set. The x-axis shows the minimum 
Tanimoto distance (calculated on Morgan R4) between any test set molecule and any training 
set molecule. As this distance increases, more molecules are removed from the training set, and 
predictions are being made on molecules that are increasingly unlike any reference molecules 
in the training set. 
 
Figure S4. Comparison of Blood Brain Barrier (BBB) and Caco-2 Permeability (Caco2) 
ROC AUC score distributions for POEM and GraphConv models using nested cluster 
validation. ​Shown are standard box plots of the distribution of ROC AUC scores from ten 
repeats of a nested cluster validation (34). Points are overlaid, and show the ROC AUC scores 
directly. Scores are compared for Naive GraphConv (NGC) (red dots), hyperparameter 
optimized GraphConv (OGC) (blue dots), and POEM (green dots). The top panel label shows 
the minimum Tanimoto distance (calculated on Morgan R4) between any test set molecule and 
any training set molecule. As this distance increases, more molecules are removed from the 
training set, and predictions are being made on molecules that are increasingly unlike any 
reference molecules in the training set. The rightmost panel label indicates which property is 
being predicted, BBB, or Caco2. 
 
 
 
Figure S5. Preliminary Observations of Regression Performance of POEM compared to 
GraphConv. ​Shown are standard box plots of the distribution of root mean squared error on the 
test set from ten repeats of a cluster validation (34). The errors are examined for 4 properties 
(each chart) and are compared for Naive GraphConv (NGC) (orange boxes), hyperparameter 
optimized GraphConv (OGC) (green boxes), and POEM (blue boxes). The x-axis shows the 
minimum permitted Tanimoto distance (calculated on Morgan R4) between any test set 
molecule and any training set molecule. As this distance increases, more molecules are 
removed from the training set, and predictions are being made on molecules that are 
increasingly unlike any reference molecules in the training set. 
 
 
  
Supplemental References for Datasets 
 
Absorption and Distribution 
BBB - Blood Brain Barrier 
The blood brain barrier is an integral part of the central nervous system that protects the brain 
and spinal column for potentially hazardous material, including xenobiotic drugs. This model will 
predict whether or not a small molecule will likely traverse the complex filtering mechanism of 
the capillaries that carry blood to the brain and spinal cord tissue. 
Dataset size: 1585 (​1276 Passes BBB | 309 Does not pass BBB)  
● Shen J., et al. Estimation of ADME Properties with Substructure Pattern Recognition. J. 
Chem. Inf. Model. 50, 1034-1041 (2010) 
 
Caco2 - Model for Intestinal Absorption 
The Caco-2 cell monolayer is an established in vitro model that screens molecules for their 
intestinal absorption and efflux liabilities. This model predicts if query ligands will be permeable 
in a Caco-2 cell monolayer experiment. In this binary classifier, the intestinal permeability value 
of 8×10−6 cm/s is used to determine whether a query ligand is permeable 
Dataset: 522 (​231 Permeable | 291 Not permeable) 
● The, H. P., et al. In Silico Prediction of Caco-2 Cell Permeability by a Classification 
QSAR Approach. Mol Inform. 30, 376-385 (2011) 
 
HIA - Human Intestinal Absorption Human 
Intestinal Absorption is the process through which orally administered drugs are absorbed from 
the intestine into the bloodstream. This model predicts whether a query ligand will likely be 
absorbed in the gut. In this binary classifier, the fraction threshold of 30% is used to determine 
whether a query ligand is absorbed through the intestine.  
Dataset: 578 (​500 Absorbed | 78 Not absorbed) 
● Shen J., et al. Estimation of ADME Properties with Substructure Pattern Recognition. J. 
Chem. Inf. Model. 50, 1034-1041 (2010) 
 
HOB - Human Oral Bioavailability 
Human Oral Bioavailability is the fraction of an orally administered drug that is absorbed and 
reaches systemic circulation. In this binary classifier, the fraction threshold of 50% is used to 
determine whether a query ligand is orally bioavailable.  
Dataset: 995 (​509 orally bioavailable | 486 Not orally bioavailable) 
● Kim M., et al. Critical Evaluation of Human Oral Bioavailability for Pharmaceutical Drugs 
by Using Various Cheminformatics Approaches. Pharm Res. 31, 1002-1014 (2014) 
 
Excretion 
PgpI - Inhibitor of p-glycoprotein 1  
P-glycoprotein 1 is an ATP-dependent drug efflux pump for xenobiotic compounds with broad 
substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant 
cells and often mediates the development of resistance to anticancer drugs. This model will 
predict whether a query ligand will likely inhibit p-gp, resulting in an a predicted accumulation of 
xenobiotic compounds, a key consideration in drug safety and drug-drug interactions. 
Dataset: 1216 (​650 Inhibits Pgp | 566 Does not inhibit Pgp) 
● Bocci G., et al. ADME-Space: a new tool for medicinal chemists to explore ADME 
properties. Scientific Reports. 7, 6359 (2017)  
 
PgpR - Substrate of p-glycoprotein 1  
P-glycoprotein 1 is an ATP-dependent drug efflux pump for xenobiotic compounds with broad 
substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant 
cells and often mediates the development of resistance to anticancer drugs. This model will 
predict if a query ligand is a substrate of p-gp, causing the molecule to be rapidly cleared from 
the cell impacting the drug efficacy.  
Dataset: 929 (​445 Pgp substrate | 484 Not a Pgp substrate) 
● Levatic J., et al. Accurate Models for P-gp Drug Recognition Induced from a Cancer Cell 
Line Cytotoxicity Screen. J. Med. Chem. 56, 5691-5708 (2013) 
 
Metabolism 
CYP2C9I - Inhibitor of CYP2C9  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely inhibit the activity of CYP2C9, an important consideration for drug-contraindications, 
efficacy, and overall drug safety.  
Dataset: 691 (166 Yes | 525 No) 
References:  
Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and substrates by 
using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005)  
 
CYP2C9S - Substrate of CYP2C9  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely be a substrate for CYP2C9 and will likely be metabolised by the enzyme, an important 
consideration for drug half-life, efficacy, and overall drug safety.  
Dataset: 691 (​143 Yes | 548 No) 
● Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and 
substrates by using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005)  
 
CYP2D6I - Inhibitor of CYP2D6  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely inhibit the activity of CYP2D6, an important consideration for drug-contraindications, 
efficacy, and overall drug safety. 
Dataset: 691 (​178 Yes | 513 No)  
● Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and 
substrates by using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005)  
 
CYP2D6S - Substrate of CYP2D6  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely be a substrate for CYP2D6 and will likely be metabolised by the enzyme, an important 
consideration for drug half-life, efficacy, and overall drug safety.  
Dataset: 690 (​195 Yes | 495 No) 
● Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and 
substrates by using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005)  
 
CYP3A4I - Inhibitor of CYP3A4  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely inhibit the activity of CYP2C9, an important consideration for drug-contraindications, 
efficacy, and overall drug safety. 
Dataset: 690 (​238 Yes | 452 No) 
● Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and 
substrates by using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005)  
 
CYP3A4S - Substrate of CYP3A4  
Cytochrome P450 enzymes are essential for the metabolism of many medications. Although this 
class has more than 50 enzymes, six of them metabolize 90 percent of drugs, with the two most 
significant enzymes being CYP3A4 and CYP2D6. This model predicts whether the ligand will 
likely be a substrate for CYP3A4 and and will likely be metabolised by the enzyme, an important 
consideration for drug half-life, efficacy, and overall drug safety.  
Dataset: 691 (362 Yes | 329 No) 
● Yap CW., et al. Prediction of cytochrome P450 3A4, 2D6, and 2C9 inhibitors and 
substrates by using support vector machines.J. Chem. Inf. Model. 45, 982-992 (2005) 
 
Toxicity: 
AMES - A Mutagenicity Assay 
The Ames test is an in vitro assay that utilizes bacteria to assay potential for inducing mutation 
within an organism's genetic material. The biological assays ability to assess the mutagenic 
potential of chemical compounds is a common method for evaluating potential drugs. This 
model predicts whether a query ligand will likely test positive for being mutagenic in an Ames 
test.  
Dataset: 6505 (​3496 Yes | 3009 No) 
● Hansen K., et al. Benchmark Data Set for in Silico Prediction of Ames Mutagenicity. J. 
Chem. Inf. Model. 49, 2077-2081 (2009)  
 
AR - Androgen Receptor Agonist  
Androgen receptors are nuclear receptors that are activated by binding androgenic hormones, 
testosterone, or dihydrotestosterone and play a key biological role in regulating gene 
expression, particularly in the maintenance of the male sexual characteristics. Drug molecules 
that activate these receptors impacts both physical and mental health. This model will predict 
whether a query ligand will likely agonize androgen receptors, a critical consideration for drug 
safety.  
Dataset: 5905 (​224 Yes | 5681 No) 
● Huang R., et al. Tox21 Challenge to Build Predictive Models of Nuclear Receptors and 
Stress Response Pathways as Mediated by Exposure to Environmental Toxicants and 
Drugs. Front. Environ. Sci. doi: 10.3389/978-2-88945-197-5 (2017)  
 
Carcin - Carcinogenic potency  
Carcinogenic potency is a metric used to quantify the cancer risk associated with exposure to a 
given chemical. Depending on the application, humans may be exposed to large volumes of 
small molecule drugs, making it critical to estimate carcinogenic potency to assess drug safety.  
Dataset: 796 (​415 Yes | 381 No) 
● Fjodorova N., et al. Rodent Carcinogenicity Dataset. Dataset Papers in Medicine. 2013, 
361615 (2013)  
 
ERa - Estrogen receptor 1 Agonist  
Estrogen receptor 1 is a nuclear receptor activated by the sex hormone estrogen and is 
responsible for maintaining the female sexual phenotype. Small molecules can potentially 
modulate this receptor, which would greatly impact human health, making evaluation of this 
property critical to establish drug safety. This model will predict whether a query ligand will act 
like an agonist to estrogen receptor 1.  
Dataset: 3235 (​2593 Yes | 642 No) 
References:  
● Ng HW., et al. Development and Validation of Decision Forest Model for Estrogen 
Receptor Binding Prediction of Chemicals Using Large Data Sets. Chem Res Toxicol. 
28, 2343-2351 (2015)  
 
hPXR - Human pregnane X receptor agonist  
Human pregnane X is a promiscuous nuclear receptor that acts as a sensor for xenobiotic 
compounds. Some of PXR protein activators are steroid hormones, bile acids, and fat-soluble 
vitamins. This model will predict whether a query molecule will act like an agonist to human 
pregnane X receptor.  
Dataset: 1709 (​172 Yes | 1537 No) 
References: 
● AbdulHameed M. D. M., et al. Predicting Rat and Human Pregnane X Receptor 
Activators Using Bayesian Classification Models. Chem. Res. Toxicol. 29, 1729-1740 
(2016) 
 
Regression Datasets: 
 
ESOL 
ESOL is a molecular solubility dataset for 1128 compounds.  Retrieved from Moleculenet.ai 
Dataset: 1128 Compounds 
● Delaney, John S. "ESOL: estimating aqueous solubility directly from molecular 
structure." Journal of chemical information and computer sciences 44.3 (2004): 
1000-1005. 
● Zhenqin Wu, Bharath Ramsundar, Evan N. Feinberg, Joseph Gomes, Caleb Geniesse, 
Aneesh S. Pappu, Karl Leswing, Vijay Pande, MoleculeNet: A Benchmark for Molecular 
Machine Learning, arXiv preprint, arXiv: 1703.00564, 2017. 
 
Freesolv 
FreeSolv is another common benchmark for regression models of small molecules.  The dataset 
contains experimentally measured free energy of solvation for 642 compounds.  Retrieved from 
Moleculenet.ai 
Dataset: 642 Compounds 
● Mobley, David L., and J. Peter Guthrie. "FreeSolv: a database of experimental and 
calculated hydration free energies, with input files." Journal of computer-aided molecular 
design 28.7 (2014): 711-720. 
● Zhenqin Wu, Bharath Ramsundar, Evan N. Feinberg, Joseph Gomes, Caleb Geniesse, 
Aneesh S. Pappu, Karl Leswing, Vijay Pande, MoleculeNet: A Benchmark for Molecular 
Machine Learning, arXiv preprint, arXiv: 1703.00564, 2017. 
 
Lipholicity 
A dataset of 4200 curated, experimentally-derived, octanol/water distribution coefficients to 
describe molecular lipophilicity.  Originally deposited in Chembl, but retrieved from 
Moleculenet.ai 
Dataset: 4200 Compounds 
● Hersey, A. ChEMBL Deposited Data Set - AZ dataset; 2015. 
https://doi.org/10.6019/chembl3301361 
● Zhenqin Wu, Bharath Ramsundar, Evan N. Feinberg, Joseph Gomes, Caleb Geniesse, 
Aneesh S. Pappu, Karl Leswing, Vijay Pande, MoleculeNet: A Benchmark for Molecular 
Machine Learning, arXiv preprint, arXiv: 1703.00564, 2017. 
 
LogS 
The aqueous solubility, logS, of organic molecules play a large role in the expected ADME 
properties of a small molecule drug. This model uses experimental data that measured the 
solubility, S, of organic molecules at 20-25°C in mol/L.  
Dataset: 1675 
● Wang, J., et al. Development of reliable aqueous solubility models and their application 
in drug-like analysis. Journal of Chemical Information and Modeling. 47, 1395-1404, 
(2007) 
● Hou, T., et al. ADME Evaluation in Drug Discovery. 4. Prediction of Aqueous Solubility 
Based on Atom Contribution Approach. Journal of Chemical Information and Computer 
Sciences. 44, 266-275, (2004) 
